Cardinal 303

California, February 20: Cardinal Health 303 Inc., formerly known as Alaris Medical Systems Inc has signed an amended consent decree to correct violations of current Good Manufacturing Practice (cGMP) requirements in the company's infusion pumps.

The U.S. Food and Drug Administration announced today that the California device manufacturer and three of its top executives have agreed to the new ruling.

Infusion pumps are devices intended for controlled delivery of intravenous solutions and medications to patients.